The LiverTox Paradox-Gaps between Promised Data and Reality Check

Idiosyncratic Drug-Induced Liver Injury (iDILI) and Herb-Induced Liver Injury (HILI): Diagnostic Algorithm Based on the Quantitative Roussel Uclaf Causality Assessment Method (RUCAM)

(2021) Rolf Teschke et al.   Diagnostics

Idiosyncratic Drug Induced Liver Injury, Cytochrome P450, Metabolic Risk Factors and Lipophilicity: Highlights and Controversies

(2021) Rolf Teschke et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Knowledge Mapping of Drug-Induced Liver Injury: A Scientometric Investigation (2010–2019)

(2020) Lixin Ke et al.   Frontiers in Pharmacology

Roussel Uclaf Causality Assessment Method for Drug-Induced Liver Injury: Present and Future

(2019) Gaby Danan et al.   Frontiers in Pharmacology

Drug-Induced Liver Injury: Biomarkers, Requirements, Candidates, and Validation

(2019) Lucy Meunier et al.   Frontiers in Pharmacology

Drug-Induced Liver Injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) Still Used 25 Years After Its Launch?

(2018) Gaby Danan et al.   DRUG SAFETY

Clinical characteristics and outcomes of traditional Chinese medicine-induced liver injury: a systematic review

(2018) Ran Wang et al.   Expert Review of Gastroenterology & Hepatology

Highlights of drug - and herb- induced liver injury in the literature from 2016: how best to translate new information into clinical practice?

(2017) Omar Shahbaz et al.   Expert Opinion on Drug Metabolism & Toxicology

Associations of Drug Lipophilicity and Extent of Metabolism with Drug-Induced Liver Injury

(2017) Kristin McEuen et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Drug-Induced Liver Injury: Expanding Our Knowledge by Enlarging Population Analysis With Prospective and Scoring Causality Assessment

(2015) Rolf Teschke et al.   GASTROENTEROLOGY

Categorization of drugs implicated in causing liver injury: Critical assessment based on published case reports

(2015) Einar S. Björnsson et al.   HEPATOLOGY

RUCAM in Drug and Herb Induced Liver Injury: The Update

(2015) Gaby Danan et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

A comprehensive study of the association between drug hepatotoxicity and daily dose, liver metabolism, and lipophilicity using 975 oral medications

(2015) Zuquan Weng et al.   Oncotarget

Liver Safety Assessment in Special Populations (Hepatitis B, C, and Oncology Trials)

(2014) Gerd A. Kullak-Ublick et al.   DRUG SAFETY

Incidence, Presentation, and Outcomes in Patients With Drug-Induced Liver Injury in the General Population of Iceland

(2013) Einar S. Björnsson et al.   GASTROENTEROLOGY

LiverTox: A website on drug-induced liver injury

(2012) Jay H. Hoofnagle et al.   HEPATOLOGY

High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury

(2012) Minjun Chen et al.   HEPATOLOGY

Case Definition and Phenotype Standardization in Drug-Induced Liver Injury

(2011) G P Aithal et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS